Abstract
This chapter begins with the ambitious aim of reviewing the evidence for psychosocial factors in the development and treatment of hypertension. The literature base is now nearly a century old, and comprises well over a thousand empirical and narrative manuscripts. The methodologies employed, psychological constructs of interest, and theoretical underpinnings in this research are many and varied, reflecting the numerous trends and cultural zeitgeists of the previous decades. At the time of this writing, the relationship between psychological factors and hypertension is a topic of growing interest, spurred by recent reviews and the continuing influx of prospective data from several large US-based cohort studies [1]–[4]. It is not the purpose of this paper to comprehensively review this extensive database. Rather, the intention is to provide a) an overview of the primary theories, methods of study and evidence for emotional factors in hypertension, with an emphasis on recent findings; b) a review of the multiple behavioral and physiological mechanisms proposed by researchers to bridge the association between psychological characteristics and blood pressure regulation, and c) a discussion of the evidence and implications for the treatment of psychological factors among patients with current or elevated risk for hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gerin W, Pickering TG, Glynn L et al (2000) An historical context for behavioral models of hypertension. J Psychosom Res 48:369–377
Jorgensen R S, Johnson B T, Kolodziej ME, Scheer GE (1996) Elevated blood pressure and personality: A meta-analytic review. Psychol Bull 120:293–320
Steptoe A (2000) Psychosocial factors in the development of hypertension. Ann Behav Med 32:371–375
Yan LL, Lio K, Matthews KA, Daviglus ML et al (2003) Psychosocial factors and risk of hypertension. JAMA 290:2138–2148
Chobanian AV, Bakris GL, Black HR et al (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA 289:3560–3572
Wolf-Maier K, Cooper RS, Banegas JR et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363–2369
Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290:199–206
Cote I, Gregoire JP, Moisan J (2000) Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials. Pharmacoeconomics 18:435–450
Irvine MJ, Garner DM, Olmstead MP, Logan AG (1989) Personality differences between hypertensive and normotensive individuals: influence on knowledge of hypertension status. Psychosom Med 51:537–549
Diamond EL (1982) The role of anger and hostility in essential hypertension. Psychol Bull 92:410–433
Rutledge T, Hogan BE (2002) A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosomatic Medicine 64:758–766
Davidson K, Jonas BS, Dixon KE, Markovitz JH (2000) Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Arch Intern Med 160:1495–1500
Everson SA, Kaplan GA, Goldberg DE, Salonen JT (2000) Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 35:561–567
Jonas BS, Franks P, Ingram DD (1997) Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Arch Fam Med 6:43–49
Kopp MS, Falger PR, Appels A, Szedmak S (1998) Depressive symptomatology and vital exhaustion are differentially related to behavioral risk factors for coronary artery disease. Psychosom Med 60:752–758
Brownley KA, Hurwitz BE, Schneiderman N (1999) Ethnic variations in the pharmacological and nonpharmacological treatment of hypertension: biopsychosocial perspective. Hum Biol 71:607–639
Rosenthal R, Rubin DB (1979) A note on percent variance explained as a measure of the importance of effects. J App Soc Psychol 9:395–396
Schmidt FL (1996) Statistical significance testing and cumulative knowledge in psychology: implications for training of researchers. Psychol Method 2:115–129
Rosenthal R, Rosnow RL, Rubin DB (2000) Contrasts and effect sizes in behavioral research: A correlational approach. New York, NY: Cambridge University Press
Willenheimer R (2001) Statistical significance versus clinical relevance in cardiovascular medicine. Prog Cardiovasc Dis 44:155–167
Abelson RP (1985) A variance explanation paradox: When a little is a lot. Psychol Bull 97:129–133
Greenland S, Schlesselman JJ, Criqui MH (1986) The fallacy of employing standardized regression coefficient and correlations as measures of effect. Am J Epidemiol 123:203–208
Baron R M, Kenny DA (1986) The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182
Holmbeck GN (1997) Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: Examples from the child-clinical and pediatric psychology literatures. J Consult Clin Psychol 65:599–610
Everson S, Kauhanen J, Kaplan G et al (1997) Hostility and risk of mortality and acute myocardial infarction: the mediating role of behavioral risk factors. Am J Epidemiol 146:142–152
Rutledge T, Reis SE, Olson M et al (2001) Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: the WISE study. Psychosom Med 63:282–288
Sielger IC, Peterson BL, Barefoot JC, Williams RB (1992) Hostility during late adolescence predicts coronary risk factors at mid-life. Am J Epidemiol 136:146–154
McDermott MM, Schmitt B, Wallner E (1997) Impact of medication nonadherence on coronary heart disease outcomes. Arch Intern Med 157:1921–1929
Glassman AH, Covey LS, Stetner F, Rivelli S (2001) Smoking cessation and the course of major depression: a follow-up study. Lancet 16:1929–1932
Wang PS, Bohn RL, Knight E et al (2002) Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 17:504–511
Zigelstein RC, Bush DE, Fauerbach J (1998) Depression, adherence behavior, and coronary disease outcomes. Arch Intern Med 158:808–809
Frasure-Smith N, Lesperance F, Talajic M (1995) The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol 14:388–398
Kamarck T, Jennings JR (1991) Biobehavioral factors in sudden cardiac death. Psychol Bull 109:42–75
Rozanski A, Blumenthal JA, Kaplan J (1999) Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99:2192–2217
Williams JE, Nieto FJ, Sanford CP et al (2002) The association between trait anger and incident stroke risk: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke 33:13–19
Lovallo WR, Gerin W (2003) Psychophysiological reactivity: Mechanisms and pathways to cardiovascular disease. Psychosom Med 65:36–45
Schwartz AR, Gerin W, Davidson KW et al (2003) Toward a casual model of cardiovascular responses to stress and the development of cardiovascular disease. Psychosom Med 65:22–35
Kamarck T, Lovallo WR (2003) Cardiovascular reactivity to psychological challenge: Conceptual and measurement considerations. Psychosom Med 65:9–21
Knox SS, Hausdorff J, Markovitz JH (2002) Coronary Artery Risk Development in Young Adults Study. Reactivity as a predictor of subsequent blood pressure: racial differences in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Hypertension 40:914–919
Matthews KA, Salomon K, Brady SS, Allen MT (2003) Cardiovascular reactivity to stress predicts future blood pressure in adolescence. Psychosom Med 65: 410–415
Kaplan JR, Manuck SS, Clarkson TB et al (1983) Social stress and atherosclerosis in normocholesterolemic monkeys. Science 220:733–735
Kaplan JR, Manuck SB, Adams MR et al (1987) Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 76:1365–1372
Rutledge T, Linden W (2003) Defensiveness and prospective blood pressure increases: the mediating effect of cardiovascular reactivity. Ann Behav Med 25:34–40
Allen K, Blascovich J, Mendes WB (2002) Cardiovascular reactivity and the presence of pets, friends, and spouses: the truth about cats and dogs. Psychosom Med 64:727–739
Karlin WA, Brondolo E, Schwartz J (2003) Workplace social support and ambulatory cardiovascular activity in New York city traffic agents. Psychosom Med 65:167–176
Kamarck TW, Janicki DL, Shiffman S et al (2002) Psychosocial demands and ambulatory blood pressure: a field assessment approach. Physiol Behav 77:699–704
Fauvel JP, M’Pio I, Quelin P et al (2003) Neither perceived job stress nor individual cardiovascular reactivity predict high blood pressure. Hypertension (in press)
Appel LJ, Champagne CM, Harsha DW et al (2003) Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 289:2083–2093
Jacob RG, Chesney MA, Williams DM et al (1991) Relaxation therapy for hypertension: design effects and treatment effects. Ann Behav Med 13:5–17
Linden W (1988) Biopsychological barriers to the behavioral treatment of essential hypertension. In: Linden W (Ed) Biological Barriers in Behavioral Medicine. New York, NY: Plenum Press 163–192
Linden W, Chambers LA (1994) Clinical effectiveness of non-drug therapies for hypertension: a meta-analysis. Ann Behav Med 16:35–45
Batey DM, Kaufmann PG, Raczynski JM et al (2000) Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I). Ann Epidemiol 10:45–58
Linden W, Lenz JW, Con AH (2001) Individualized stress management for primary hypertension. Arch Intern Med 161:1071–1080
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Rutledge, T. (2006). Psychological Factors in Hypertension Development and Treatment. In: Clinical Psychology and Heart Disease. Springer, Milano. https://doi.org/10.1007/978-88-470-0378-1_11
Download citation
DOI: https://doi.org/10.1007/978-88-470-0378-1_11
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0377-4
Online ISBN: 978-88-470-0378-1
eBook Packages: MedicineMedicine (R0)